Shedding Light on Shingles: The Power of Prevention

Area of Science:

• Virology
• Immunology
• Epidemiology

Background:

• Shingles (herpes zoster, HZ) stems from varicella-zoster virus (VZV) reactivation.
• Over 95% of adults over 50 have VZV antibodies, placing them at risk for HZ.
• Declining cell-mediated immunity with age contributes to increased HZ incidence and severity.

Discussion:

• HZ complications can be neurological, ophthalmological, dermatological, or visceral.
• These complications impose a significant patient and economic burden.
• Effective prevention strategies are vital for managing HZ.

Key Insights:

• HZ vaccination is a primary preventive measure against HZ and its sequelae.
• Understanding VZV reactivation and age-related immune decline is key.
• Early recognition and management of HZ complications are essential.

Outlook:

• Continued research into VZV pathogenesis and immune responses.
• Development of improved HZ prevention and treatment strategies.
• Public health initiatives to promote HZ vaccination in eligible populations.